These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38973984)

  • 1. A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries.
    Satheesh G; Gyawali B; Sun MFC; Huffman MD; Banerjee A; Perel P; Murphy A
    Glob Heart; 2024; 19(1):56. PubMed ID: 38973984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose Combination Medication (Polypills) in Andhra Pradesh, India: A Mixed-Methods Study.
    Salam A; Praveen D; Patel A; Tewari A; Webster R
    Glob Heart; 2019 Sep; 14(3):303-310. PubMed ID: 31451238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study.
    Satheesh G; Unnikrishnan MK; Sharma A
    J Pharm Policy Pract; 2019; 12():31. PubMed ID: 31636912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.
    Liu C; Zhang X; Liu C; Ewen M; Zhang Z; Liu G
    BMC Health Serv Res; 2017 Aug; 17(1):597. PubMed ID: 28836974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
    Khatib R; McKee M; Shannon H; Chow C; Rangarajan S; Teo K; Wei L; Mony P; Mohan V; Gupta R; Kumar R; Vijayakumar K; Lear SA; Diaz R; Avezum A; Lopez-Jaramillo P; Lanas F; Yusoff K; Ismail N; Kazmi K; Rahman O; Rosengren A; Monsef N; Kelishadi R; Kruger A; Puoane T; Szuba A; Chifamba J; Temizhan A; Dagenais G; Gafni A; Yusuf S;
    Lancet; 2016 Jan; 387(10013):61-9. PubMed ID: 26498706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study.
    Dzudie A; Njume E; Abanda M; Aminde L; Hamadou B; Dzekem B; Azabji M; Doualla MS; Ngowe M; Kengne AP
    PLoS One; 2020; 15(3):e0229307. PubMed ID: 32130252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to essential medicines for diabetes care: availability, price, and affordability in central Ethiopia.
    Deressa HD; Abuye H; Adinew A; Ali MK; Kebede T; Habte BM
    Glob Health Res Policy; 2024 Apr; 9(1):12. PubMed ID: 38584277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.
    van Mourik MS; Cameron A; Ewen M; Laing RO
    BMC Cardiovasc Disord; 2010 Jun; 10():25. PubMed ID: 20534118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
    Osuafor NG; Ukwe CV; Okonta M
    PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.
    Sharma A; Kaplan WA; Satheesh G; Poudyal IP; Gyawali P; Neupane D; Bhandari PM; Malla M; Sapkota S; Mishra SR
    Glob Heart; 2021 May; 16(1):38. PubMed ID: 34040951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
    Babar ZU; Lessing C; Mace C; Bissell K
    Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology.
    Saeed A; Saeed F; Saeed H; Saleem Z; Yang C; Chang J; Jiang M; Zhao M; Saqlain M; Ji W; Aziz MM; Lambojon K; Gillani AH; Hayat K; Gul S; Fang Y; Babar ZU
    Front Pharmacol; 2020; 11():595008. PubMed ID: 33708114
    [No Abstract]   [Full Text] [Related]  

  • 18. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
    Sado E; Sufa A
    BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique.
    Jessen N; Sharma A; Jones J; Auala T; Boladuadua S; Jingi A; Ferrer J; Mocumbi AO
    Glob Heart; 2023; 18(1):8. PubMed ID: 36874443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk.
    Lafeber M; Spiering W; Visseren FL; Grobbee DE; Bots ML; Stanton A; Patel A; Prabhakaran D; Webster R; Thom S; Rodgers A;
    Eur J Prev Cardiol; 2017 Jun; 24(9):951-961. PubMed ID: 28436727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.